---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-254305"
form_type: "8-K"
ticker: "KURA"
cik: "0001422143"
company_name: "Kura Oncology, Inc."
filed_at: "2022-09-29T23:59:59+00:00"
generated_at: "2026-06-23T06:40:45.850049+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# KURA Oncology amends equity plan to increase shares by 1.46M and grants PSUs to executives

## Summary
- Board approved amendment to 2014 Equity Incentive Plan to increase shares by 1,459,800, subject to stockholder approval at 2023 Annual Meeting.
- Compensation Committee and Board granted PSUs totaling 1,235,100 shares to five executive officers, contingent on stockholder approval of amendment.
- PSU vesting tied to milestones: FDA NDA approval for ziftomenib in AML, initiation of registration-enabling trial, and Phase 2 start of farnesyl transferase inhibitor combination.
- Executive officers receiving PSUs: CEO Troy Wilson (547,500), CLO Teresa Bair (146,700), CMO Stephen Dale (247,500), CCO Kirsten Flowers (146,700), COO Kathleen Ford (146,700).

## SEC filing metadata
- accession: 0001193125-22-254305
- form_type: 8-K
- ticker: KURA
- cik: 0001422143
- company_name: Kura Oncology, Inc.
- filed_at: 2022-09-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422143/000119312522254305/0001193125-22-254305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422143/000119312522254305/d388454d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-254305
- JSON: https://secwatch.observer/filing/0001193125-22-254305.json
- Plain text: https://secwatch.observer/filing/0001193125-22-254305.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.